The information contained in these releases was current on the date the releases were issued and will become outdated over time. Lilly does not assume any responsibility for updating information in these releases.
Releases
 |
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Nov 13, 2009
|
9.9 KB |
|
| |
INDIANAPOLIS, Nov 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) announced today that Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research Laboratories, will retire from Lilly effective February 28, 2010. Lilly has also announced that Jan M. Lundberg, Ph....
|
|
Deadline Extended to December 16 to Submit Nominations for Depression Awards Program
Nov 11, 2009
|
10.9 KB |
|
| |
NEW YORK, Nov 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The deadline to submit nominations for this year's Welcome Back Awards, a national awards program that honors outstanding individuals in the depression community, has been extended by one month. Nominations are now due by Wednesday, December 16, 2009.
The Welcome Back Awards...
|
|
Oncology On Canvas(SM) Launches 2010 Art Competition for Individuals Touched by Cancer
Nov 4, 2009
|
11.8 KB |
|
| |
INDIANAPOLIS, Nov 04, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- "Feel. Create. Share the hope." With these words, Lilly USA, LLC, and the National Coalition for Cancer Survivorship (NCCS) kick off the 2010 Oncology On Canvas: Expressions of a Cancer Journey Art Competition and Exhibition. The biennial competition invites residents of...
|
|
Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation'
Oct 30, 2009
|
10.4 KB |
|
| |
SAN DIEGO, Oct 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- In a speech today to the City Club of San Diego, John C. Lechleiter, Ph.D., chairman and chief executive officer of Eli Lilly and Company (NYSE: LLY), said that the engine of biopharmaceutical innovation is "broken." He offered a vision for biopharmaceutical companies to "re...
|
|
Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
Oct 29, 2009
|
13.8 KB |
|
| |
SAN DIEGO, Oct 29, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- As part of its strategy to discover and develop more biotechnology medicines, Eli Lilly and Company today officially opened a new state-of-the-art biotechnology center on the West Coast. The facility, known as the "Lilly Biotechnology Center - San Diego," is opening three mon...
|
|
Diabetes Conversation Map(TM) Education Tools Celebrate One-Year Anniversary
Oct 21, 2009
|
12.5 KB |
|
| |
MONTREAL, Oct 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- IDF World Diabetes Congress Marks Major Milestone and Availability of Tools in 68 Countries, 31 Different LanguagesThis October marks the one-year anniversary of the international launchof the ground-breaking diabetes Conversation Map(TM) education tools. Created by Healthy In...
|
|
GE and Lilly Achieve Significant Advancement in Cancer Research
Oct 21, 2009
|
10.8 KB |
|
| |
New York, NY and Indianapolis, IN - October 21, 2009 - Scientists at GE Global Research (NYSE: GE), and researchers at Eli Lilly and Company (NYSE: LLY) today announced a significant advancement in cancer research resulting from the two companies' collaboration formed in October 2007.
Working together, the research teams have deve...
|
|
Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
Oct 14, 2009
|
10.3 KB |
|
| |
INDIANAPOLIS, Oct 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced the sale of its Tippecanoe Laboratories manufacturing facility to Evonik Industries AG, one of the world's largest chemical companies. The manufacturing site, located in Lafayette, Indiana, will remain in operation with a f...
|
|
New Survey Reveals Even After 12 Years of Living With Depression Adults Still Struggle Due to Lack of Basic Information
Oct 14, 2009
|
14.3 KB |
|
| |
INDIANAPOLIS, Oct 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- A new survey of 2,001 adults living with depression revealed that despite being diagnosed for an average of 12 years, many unknowingly took actions that could have sabotaged their chances of getting well.(i) Furthermore, on average, it took about six years for respondents...
|
|
Lilly Receives Honor from Lambda Legal
Sep 28, 2009
|
7.6 KB |
|
| |
INDIANAPOLIS, Sept 28, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) received the Corporate Leadership Award from Lambda Legal at their annual benefit dinner on Friday in Indianapolis. Lilly was recognized for their efforts to further civil rights for the lesbian, gay, bisexual and transgender (LGBT) comm...
|
|
NCQA and Lilly Launch Online Quality Improvement Guide to Help Reduce Health Care Disparities and Improve Patient Care
Sep 24, 2009
|
11.3 KB |
|
| |
INDIANAPOLIS, Sept 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Lilly USA (NYSE: LLY) and the National Committee for Quality Assurance (NCQA) have collaborated to release a free online guide and resource library for health care organizations that wish to undertake quality improvement initiatives to improve culturally and linguisticall...
|
|
U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014
Sep 23, 2009
|
9.4 KB |
|
| |
INDIANAPOLIS, Sept 23, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The U.S. District Court for the Southern District of Indiana today upheld Eli Lilly and Company's (NYSE: LLY) method-of-use patents on Evista(R) (raloxifene HCl tablets). In the case of Eli Lilly and Company v. Teva Pharmaceuticals Industries Ltd., the court ruled in favo...
|
|
Lilly Announces New U.S. Affiliate Leader
Sep 22, 2009
|
7.1 KB |
|
| |
INDIANAPOLIS, Sept 22, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced that David Ricks, currently general manager of Lilly China, has been promoted to president, Lilly USA, LLC. Ricks will succeed Enrique Conterno, who was named leader of Lilly's new Diabetes Business Unit as part of a comp...
|
|
Lilly Receives 100 Percent Rating on Corporate Equality Index Survey
Sep 21, 2009
|
7.8 KB |
|
| |
INDIANAPOLIS, Sept 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) has been given a 100 percent rating on the Human Rights Campaign's (HRC) Corporate Equality Index for 2010. This is the fourth consecutive year Lilly is recognized as one of the Best Places to Work for Lesbian, Gay, Bisexual, and Transge...
|
|
Lilly Names New Business Leaders
Sep 14, 2009
|
16.1 KB |
|
| |
INDIANAPOLIS, Sept 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- In conjunction with today's announcement of a new operating model to speed innovative medicines to patients, Eli Lilly and Company (NYSE: LLY) has named the leaders of its Development Center of Excellence and its five business units: oncology, diabetes, established market...
|
|
Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients
Sep 14, 2009
|
11.6 KB |
|
| |
INDIANAPOLIS, Sept 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today unveiled a new operating model and announced a series of changes to speed medicines from its pipeline to patients. To help achieve this goal, the company will establish a Development Center of Excellence to streamline and accelerate...
|
|
Lilly Named Best Company for Blacks in Technology
Sep 2, 2009
|
7.7 KB |
|
| |
INDIANAPOLIS, Sept 02, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has been given the Epsilon "Star of Highest Magnitude" Award and has been named the best company for blacks in technology by the Black Data Processing Associates (BDPA) and WorkplaceDiversity.com. The Epsilon Awar...
|
|
Lilly Reports on Outcome of Phase III Study of Arzoxifene
Aug 18, 2009
|
10.0 KB |
|
| |
INDIANAPOLIS, Aug 18, 2009 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) announced today that initial results from its pivotal, five-year, Phase III GJAD "GENERATIONS" trial for arzoxifene met its primary endpoints of significantly reducing the risk of vertebral fracture and invasive breast cancer in postmenopausal women...
|
|
U.S. District Court Rules Against Lilly Regarding Gemzar Patent
Aug 17, 2009
|
9.9 KB |
|
| |
INDIANAPOLIS, Aug 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Eastern District of Michigan has granted a motion by Sun Pharmaceuticals for partial summary judgment. The Court's ruling invalidates Lilly's '826 patent, or method-of-use patent, for Ge...
|
|
Lilly Announces Continued Commitment to Transparency with Faculty Registry
Jul 31, 2009
|
8.2 KB |
|
| |
INDIANAPOLIS, July 31, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Today Eli Lilly and Company (NYSE: LLY) launched an online registry detailing recent payments it has made to physicians and other health care professionals - a report known as its "faculty registry." The data are for the first quarter of 2009; Lilly will update the regist...
|
|
|
